Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q2 2017 · 10-Q
Revenue$0.00$0.00— vs Q2 2016 Net Income-$1.29M-$1.29MN/M vs Q2 2016 EPS Diluted-$0.22-$0.22— vs Q2 2016 Operating Income-$888,689N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
derived
ended Jun 30, 2017 · filed Aug 14, 2017 · 45 d after period end